Endpoints for Clinical Trials in Primary Hyperoxaluria

Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy

(2019) Aliza Thompson et al.   Clinical Journal of the American Society of Nephrology

Association of Urinary Oxalate Excretion With the Risk of Chronic Kidney Disease Progression

(2019) Sushrut S. Waikar et al.   JAMA Internal Medicine

The ocular phenotype in primary hyperoxaluria type 1

(2019) Johannes Birtel et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

A simple scoring model for predicting early graft failure and postoperative mortality after liver transplantation

(2019) Rafael Diaz-Nieto et al.   Annals of Hepatology

Patients with primary hyperoxaluria type 2 have significant morbidity and require careful follow-up

(2019) Sander F. Garrelfs et al.   KIDNEY INTERNATIONAL

Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease

(2017) Vicente E. Torres et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pediatric Liver Transplantation

(2017) Nidhi Rawal et al.   PEDIATRIC CLINICS OF NORTH AMERICA

What Is the Correct Approach for Comparing GFR by Different Methods across Levels of GFR?

(2016) A. D. Rule et al.   Clinical Journal of the American Society of Nephrology

Calcium Oxalate Stone Fragment and Crystal Phagocytosis by Human Macrophages

(2016) Sergei Kusmartsev et al.   JOURNAL OF UROLOGY

Simultaneous analysis of urinary metabolites for preliminary identification of primary hyperoxaluria

(2016) Oliver Clifford-Mobley et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Predictors of Incident ESRD among Patients with Primary Hyperoxaluria Presenting Prior to Kidney Failure

(2015) F. Zhao et al.   Clinical Journal of the American Society of Nephrology

Tools to Improve the Accuracy of Kidney Stone Sizing with Ultrasound

(2015) Barbrina Dunmire et al.   JOURNAL OF ENDOUROLOGY

Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria

(2015) K. Hopp et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria

(2015) Xiaojing Tang et al.   KIDNEY INTERNATIONAL

The comparability of oxalate excretion and oxalate:creatinine ratio in the investigation of primary hyperoxaluria: review of data from a referral centre

(2015) Oliver Clifford-Mobley et al.   ANNALS OF CLINICAL BIOCHEMISTRY

GFR Decline as an End Point in Trials of CKD: A Viewpoint From the FDA

(2014) Aliza Thompson et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Sustained Pyridoxine Response in Primary Hyperoxaluria Type 1 Recipients of Kidney Alone Transplant

(2014) E. C. Lorenz et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Vitamin B6 in Primary Hyperoxaluria I: First Prospective Trial after 40 Years of Practice

(2014) H. Hoyer-Kuhn et al.   Clinical Journal of the American Society of Nephrology

Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1

(2013) Sonia Fargue et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

The chaperone role of the pyridoxal 5′-phosphate and its implications for rare diseases involving B6-dependent enzymes

(2013) Barbara Cellini et al.   CLINICAL BIOCHEMISTRY

Fostering Innovation, Advancing Patient Safety: The Kidney Health Initiative

(2013) P. Archdeacon et al.   Clinical Journal of the American Society of Nephrology

NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy

(2013) Felix Knauf et al.   KIDNEY INTERNATIONAL

Primary Hyperoxaluria

(2013) Pierre Cochat et al.   NEW ENGLAND JOURNAL OF MEDICINE

Four of the Most Common Mutations in Primary Hyperoxaluria Type 1 Unmask the Cryptic Mitochondrial Targeting Sequence of Alanine:glyoxylate Aminotransferase Encoded by the Polymorphic Minor Allele

(2012) Sonia Fargue et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion

(2012) Shrikant R. Mulay et al.   JOURNAL OF CLINICAL INVESTIGATION

Clinical Effectiveness Protocols for Imaging in the Management of Ureteral Calculous Disease: AUA Technology Assessment

(2012) Pat Fox Fulgham et al.   JOURNAL OF UROLOGY

Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment

(2012) P. Cochat et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Transplantation Outcomes in Primary Hyperoxaluria

(2010) E. J. Bergstralh et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Evolution of Causes and Risk Factors for Mortality Post-Liver Transplant: Results of the NIDDK Long-Term Follow-Up Study

(2010) K. D. S. Watt et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Pre-emptive liver transplantation for primary hyperoxaluria (PH-I) arrests long-term renal function deterioration

(2010) M. T. P. Perera et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Excellent renal function and reversal of nephrocalcinosis 8 years after isolated liver transplantation in an infant with primary hyperoxaluria type 1

(2010) Mónica Galanti et al.   PEDIATRIC NEPHROLOGY

Effect of conservative treatment on the renal outcome of children with primary hyperoxaluria type 1

(2009) Sonia Fargue et al.   KIDNEY INTERNATIONAL

The primary hyperoxalurias

(2009) Bernd Hoppe et al.   KIDNEY INTERNATIONAL

Genotype–phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome

(2009) Jérôme Harambat et al.   KIDNEY INTERNATIONAL

24-h uric acid excretion and the risk of kidney stones

(2007) G.C. Curhan et al.   KIDNEY INTERNATIONAL